![]() |
|
|
-D-Glucuronide
Departments of
Clinical Pharmacology (B.C.S., B.A.F.) and
Clinical
Chemistry (P.R.P.), The Queen Elizabeth Hospital; and the
Department of
Clinical and Experimental Pharmacology (B.C.S.), University of Adelaide
Acyl glucuronides are electrophilic metabolites that are readily
hydrolyzed, undergo intramolecular rearrangement, and bind covalently
to endogenous proteins. Gemfibrozil is a fibrate lipid-lowering agent
that is extensively metabolized to an acyl glucuronide conjugate in
humans. The aims of this study were to examine the interactions of
1-O-gemfibrozil-
-D-glucuronide with human
serum albumin. The degradation of
1-O-gemfibrozil-
-D-glucuronide (~200 µM)
was examined in vitro during incubations at 37°C with
phosphate buffer (pH 7.4 or 9.0), solutions of human serum albumin (pH
7.4), or fresh human plasma (pH 7.4). The effects of diazepam,
oxyphenbutazone, and gemfibrozil on the degradation of
1-O-gemfibrozil-
-D-glucuronide, and its
reversible binding to albumin were also studied. A pilot in
vivo study was performed on two patient volunteers administered 1 g/day po gemfibrozil.
1-O-Gemfibrozil-
-D-glucuronide was unstable, with degradation half-lives in buffer of 4.1 hr and 44 hr at pH 9.0 and
7.4, respectively; and 8.5 hr and 5.5 hr in pH 7.4 solutions of human
serum albumin or fresh plasma, respectively. Degradation was dependent
on pH and the presence of albumin, which seemed to accelerate the
intramolecular rearrangement and hydrolysis of the conjugate.
1-O-Gemfibrozil-
-D-glucuronide was highly
reversibly bound to albumin, with a mean unbound fraction of 0.028, and
its degradation seemed to be related to the degree of reversible
binding. Hydrolysis and covalent binding were associated with the site II binding domain on albumin, because only diazepam inhibited these
reactions. However, intramolecular rearrangement was increased when
binding to the site I domain was inhibited. Covalent binding was also
detected in vivo to human plasma proteins. The half-life of
the gemfibrozil-protein adducts was 2.5-3 days. Albumin plays an
important role in the disposition of acyl glucuronides by acting as:
i) a transporter protein; ii) a potential
catalyst for their degradation and, therefore, clearance; and
iii) a target for covalent adduct formation.
This article has been cited by other articles:
![]() |
Y. Mano, T. Usui, and H. Kamimura The UDP-Glucuronosyltransferase 2B7 Isozyme Is Responsible for Gemfibrozil Glucuronidation in the Human Liver Drug Metab. Dispos., November 1, 2007; 35(11): 2040 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, M. Neuvonen, X. Wen, J. T. Backman, and P. J. Neuvonen Gemfibrozil Inhibits CYP2C8-Mediated Cerivastatin Metabolism in Human Liver Microsomes Drug Metab. Dispos., December 1, 2002; 30(12): 1352 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, X. Wen, J. T. Backman, and P. J. Neuvonen Effect of Albumin and Cytosol on Enzyme Kinetics of Tolbutamide Hydroxylation and on Inhibition of CYP2C9 by Gemfibrozil in Human Liver Microsomes J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 43 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Skopp and L. Potsch Stability of 11-Nor-{Delta}9-carboxy-tetrahydrocannabinol Glucuronide in Plasma and Urine Assessed by Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., February 1, 2002; 48(2): 301 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sabordo, B. C. Sallustio, A. M. Evans, and R. L. Nation Hepatic Disposition of the Acyl Glucuronide1-O-Gemfibrozil-beta -D-Glucuronide: Effects of Dibromosulfophthalein on Membrane Transport and Aglycone Formation J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 414 - 420. [Abstract] [Full Text] |
||||
![]() |
M. Wang and R. G. Dickinson Disposition and Covalent Binding of Diflunisal and Diflunisal Acyl Glucuronide in the Isolated Perfused Rat Liver Drug Metab. Dispos., February 1, 1998; 26(2): 98 - 104. [Abstract] [Full Text] |
||||